[Elsevier] Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial

MED92 Post time The day before yesterday 15:17 | Show all posts |Read mode
This post will be closed automatically in 2026-06-18 15:16
Reward10points

Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial

Publication History:
Published February 9, 2023

DOI: 10.1016/S0140-6736(22)02600-9 External LinkAlso available on ScienceDirect External Link
Copyright: © 2022 Elsevier Ltd. All rights reserved.

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Sweetums33 Post time The day before yesterday 15:17 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    5720

Return to the list